13005-29-3 Usage
Uses
Used in Chemical Production:
2,2-DIMETHYLUNDECANOIC ACID is used as a key component in the production of various industrial chemicals and pharmaceuticals. Its unique structure and properties make it suitable for creating a wide range of products.
Used in Lubricant Manufacturing:
In the lubricant industry, 2,2-DIMETHYLUNDECANOIC ACID is used as a base material for developing high-quality lubricants. Its chemical properties contribute to the performance and efficiency of these lubricants.
Used in Plasticizer Production:
2,2-DIMETHYLUNDECANOIC ACID is utilized as a raw material in the production of plasticizers, which are additives that increase the flexibility and workability of plastics.
Used in Surfactant Manufacturing:
2,2-DIMETHYLUNDECANOIC ACID is also used as a building block for the synthesis of surfactants, which are essential in various industries for their ability to reduce surface tension between liquids and solids.
Used in Bio-based Polymers and Materials Research:
2,2-DIMETHYLUNDECANOIC ACID has been studied for its potential use as a starting material for the development of novel bio-based polymers and materials, indicating its importance in the field of sustainable chemistry and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 13005-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,0 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13005-29:
(7*1)+(6*3)+(5*0)+(4*0)+(3*5)+(2*2)+(1*9)=53
53 % 10 = 3
So 13005-29-3 is a valid CAS Registry Number.
13005-29-3Relevant academic research and scientific papers
Inhibitors of Acyl-CoA:cholesterol acyltransferase. I. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents
Roth,Blankley,Hoefle,Holmes,Roark,Trivedi,Essenburg,Kieft,Krause,Stanfield
, p. 1609 - 1617 (2007/10/02)
A series of fatty acid anilides was prepared, and compounds were tested for their ability to inhibit the enzyme acyl-CoA:cholesterol acyltransferase (ACAT) in vitro and to lower plasma total cholesterol and elevate high- density lipoprotein cholesterol in cholesterol-fed rats in vivo. The compounds reported were found to fall into two subclasses with different anilide SAR. For nonbranched acyl analogues, inhibitory potency was found to be optimal with bulky 2,6-dialkyl substitution. For α-substituted acyl analogues, there was little dependence of in vitro potency on anilide substitution and 2,4,6-trimethoxy was uniquely preferred. Most of the potent inhibitors (IC50 50 nM) were found to produce significant reductions in plasma total cholesterol in cholesterol-fed rats. Additionally, in vivo activity could be improved significantly by the introduction of α,α- disubstitution into the fatty acid portion of the molecule. A narrow group of α,α-disubstituted trimethoxyanilides, exemplified by 2,2-dimethyl-N-(2,4,6- trimethoxyphenyl)dodecanamide (39), was found to not only lower plasma total cholesterol (-60%) in cholesterol-fed rats but also elevate levels of high- density lipoprotein cholesterol (+94%) in this model at the screening dose of 0.05% in the diet (ca. 50 mg/kg).
